Skip to content

Pilot Study to Evaluate Ear Acupressure Effects in Treating Seasonal Allergic Rhinitis

Pilot Study to Evaluate Ear Acupressure Effects in Treating Seasonal Allergic Rhinitis

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01921348
Enrollment
18
Registered
2013-08-13
Start date
2013-08-31
Completion date
2014-08-31
Last updated
2017-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Seasonal Allergic Rhinitis

Keywords

Hay Fever, Hayfever, Pollen Allergy, Pollinosis, Seasonal Allergic Rhinitis

Brief summary

We hypothesize that ear acupressure will be effective in treating seasonal allergic rhinitis by changing the immune parameters and the psychological impact factors are associated with ear acupressure treatment outcome.

Detailed description

The purpose of the study is to investigate the clinical potential of ear acupressure in treating seasonal allergic rhinitis. We hypothesize that ear acupressure will be effective in treating seasonal allergic rhinitis by changing the immune parameters and the psychological impact factors such as expectation, stress, depression, and anxiety can moderate the ear acupressure treatment effectiveness in allergic rhinitis by influencing the immune parameters.

Interventions

DEVICEacupressure pellets

The treatment group will have acupressure pellets placed in pre-determined acupressure point on the ear that relates to rhinitis.

Sponsors

University of Mississippi Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Seasonal allergic rhinitis was diagnosed both by history and clinical examination and by the presence at positive skin prick tests * All participants need to have at least 2 years of seasonal allergic rhinitis symptoms and a positive skin prick test to one or more pollen allergens

Exclusion criteria

* use of systemic corticosteroids within past 3 months period, * active asthma, * hearing aid usage, * history of adhesive tape allergy, * history of metal allergy, * HIV, * hepatitis B or C, * history of hematologic, autoimmune, or malignant disease, * pregnancy or lactation, * ear acupressure (EAP) or acupuncture for respiratory disease within the last 6 months

Design outcomes

Primary

MeasureTime frameDescription
Rhinoconjunctivitis Quality of Life Questionnaire (Nasal Symptoms Domain Only)8 weeksRQLQ is an instrument that has 28 items in 7 domains (sleep, non-rhinoconjuctivitis symptoms, practical problems, nasal symptoms, eye symptoms activity limitations and emotional function). Participants are asked to recall impairments experienced during the previous week and to respond to each item on a 7-point scale (0=no impairment; 6=maximum impairment). In this protocol, we used the nasal symptoms domain only; 4 questions, total scale ranges from 0 minimum to 24 maximum. Longitudinal changes of nasal symptoms domain total were reported from baseline to 8 weeks.

Secondary

MeasureTime frameDescription
Psychological Measures8 weeksEffects of ear acupressure on immune biomarkers based upon psychological differences including perceived stress, anxiety, depression and worry.

Other

MeasureTime frameDescription
Immune Biomarkers8 weeksChanges in Regulatory T(Treg), Type 1 Regulatory T (Tr1), T helper 3(TH3), T helper 1(TH1), T helper 2(TH2)cells, salivary cortisol, alpha amylase, Interferon gamma(IFNg), Interleukin 4(IL4) and Interleukin 10(IL10) cytokine production from baseline to 8 weeks.

Countries

United States

Participant flow

Participants by arm

ArmCount
Treatment
34 participants will be randomized to wear acupressure pellets in the designated acupressure points and apply pressure as instructed by the study personnel. acupressure pellets: The treatment group will have acupressure pellets placed in pre-determined acupressure point on the ear that relates to rhinitis.
9
Sham
33 participants will be randomized to wear acupressure pellets in non-specific areas of the ear and apply pressure as instructed by the study personnel. acupressure pellets: The sham group will have acupressure pellets placed in a pre-determined non-specific acupressure point on the ear that is not related to rhinitis.
9
Total18

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up02
Overall StudyWithdrawal by Subject10

Baseline characteristics

CharacteristicShamTreatmentTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
9 Participants9 Participants18 Participants
Age, Continuous36.9 years
STANDARD_DEVIATION 12.1
41.9 years
STANDARD_DEVIATION 12.1
39.4 years
STANDARD_DEVIATION 12
Region of Enrollment
United States
9 participants9 participants18 participants
Sex: Female, Male
Female
9 Participants8 Participants17 Participants
Sex: Female, Male
Male
0 Participants1 Participants1 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 90 / 9
other
Total, other adverse events
0 / 90 / 9
serious
Total, serious adverse events
0 / 90 / 9

Outcome results

Primary

Rhinoconjunctivitis Quality of Life Questionnaire (Nasal Symptoms Domain Only)

RQLQ is an instrument that has 28 items in 7 domains (sleep, non-rhinoconjuctivitis symptoms, practical problems, nasal symptoms, eye symptoms activity limitations and emotional function). Participants are asked to recall impairments experienced during the previous week and to respond to each item on a 7-point scale (0=no impairment; 6=maximum impairment). In this protocol, we used the nasal symptoms domain only; 4 questions, total scale ranges from 0 minimum to 24 maximum. Longitudinal changes of nasal symptoms domain total were reported from baseline to 8 weeks.

Time frame: 8 weeks

Population: Enrollment targets were not met for both arms/groups.

ArmMeasureValue (MEAN)Dispersion
TreatmentRhinoconjunctivitis Quality of Life Questionnaire (Nasal Symptoms Domain Only)2.36 units on a scaleStandard Deviation 0.89
ShamRhinoconjunctivitis Quality of Life Questionnaire (Nasal Symptoms Domain Only)2.07 units on a scaleStandard Deviation 1.31
Secondary

Psychological Measures

Effects of ear acupressure on immune biomarkers based upon psychological differences including perceived stress, anxiety, depression and worry.

Time frame: 8 weeks

Population: Since the immune biomarker frozen blood samples were not analyzed (due to not meeting recruitment goals), the effects of ear accupressure based upon psychological differences could not be analyzed.

Other Pre-specified

Immune Biomarkers

Changes in Regulatory T(Treg), Type 1 Regulatory T (Tr1), T helper 3(TH3), T helper 1(TH1), T helper 2(TH2)cells, salivary cortisol, alpha amylase, Interferon gamma(IFNg), Interleukin 4(IL4) and Interleukin 10(IL10) cytokine production from baseline to 8 weeks.

Time frame: 8 weeks

Population: Blood samples were collected and frozen for batch analysis, but not analyzed for data since recruitment goals were not met.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026